These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24130008)

  • 1. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.
    Bashir MR; Mody R; Neville A; Javan R; Seaman D; Kim CY; Gupta RT; Jaffe TA
    J Magn Reson Imaging; 2014 Jul; 40(1):113-8. PubMed ID: 24130008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent.
    Huang SY; Kim CY; Miller MJ; Gupta RT; Lessne ML; Horvath JJ; Boll DT; Evans PD; Befera NT; Krishnan P; Chan JL; Merkle EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):208-14. PubMed ID: 23789677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
    Shahrouki P; Khan SN; Yoshida T; Iskander PJ; Ghahremani S; Finn JP
    Pediatr Radiol; 2022 Mar; 52(3):501-512. PubMed ID: 34936018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
    Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
    AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
    Schnorr J; Taupitz M; Schellenberger EA; Warmuth C; Fahlenkamp UL; Wagner S; Kaufels N; Wagner M
    Rofo; 2012 Feb; 184(2):105-12. PubMed ID: 22179768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
    Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
    Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.
    Pfeil A; Betge S; Poehlmann G; Boettcher J; Drescher R; Malich A; Wolf G; Mentzel HJ; Hansch A
    Eur J Radiol; 2012 Mar; 81(3):547-52. PubMed ID: 21349675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA).
    Enden T; Storås TH; Negård A; Haig Y; Sandvik L; Gjesdal KI; Sandset PM; Kløw NE
    J Magn Reson Imaging; 2010 Feb; 31(2):416-24. PubMed ID: 20099355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
    Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral MRA with k-space segmentation and blood-pool contrast agent.
    Kinner S; Zenge MO; Heilmaier C; de Greiff A; Vogt FM; Ladd ME; Barkhausen J; Quick HH
    Acad Radiol; 2011 Jan; 18(1):113-9. PubMed ID: 20947388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
    Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
    Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance venography of the upper venous system with blood pool contrast agent: comparison of two different T1-weighted sequences.
    Boettcher J; Pfeil A; Wolf G; Hansch A
    Clin Imaging; 2013; 37(2):245-50. PubMed ID: 23465975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadofosveset-enhanced MR imaging for the preoperative evaluation of potential living kidney donors: correlation with intraoperative findings.
    Kuhlemann J; Blondin D; Grotemeyer D; Zgoura P; Reichelt D; Heinen W; Scherer A; Lanzman RS
    Rofo; 2010 Nov; 182(11):1001-9. PubMed ID: 20922646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
    Rapp JH; Wolff SD; Quinn SF; Soto JA; Meranze SG; Muluk S; Blebea J; Johnson SP; Rofsky NM; Duerinckx A; Foster GS; Kent KC; Moneta G; Middlebrook MR; Narra VR; Toombs BD; Pollak J; Yucel EK; Shamsi K; Weisskoff RM
    Radiology; 2005 Jul; 236(1):71-8. PubMed ID: 15987963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadofosveset-enhanced magnetic resonance venography in patients with venous pathology of the lower limbs - Comparison of diagnostic image quality and inter-rater variability with gadobutrol venography and computed tomography venography.
    Åkesson M; Lehti L; Höglund P; Åkeson P; Wassélius J
    Phlebology; 2016 Dec; 31(10):737-743. PubMed ID: 26631538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhanced MR venography with gadofosveset trisodium: evaluation of the intracranial and extracranial venous system.
    Kramer LA; Cohen AM; Hasan KM; Heimbigner JH; Barreto AD; Brod SA; Narayana PA; Wolinsky JS
    J Magn Reson Imaging; 2014 Sep; 40(3):630-40. PubMed ID: 24273083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T.
    Lin K; Lloyd-Jones DM; Spottiswoode B; Bi X; Liu Y; Lu B; Xue H; Wang Y; Li D; Carr JC
    Invest Radiol; 2014 Apr; 49(4):243-8. PubMed ID: 24473364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced whole-heart coronary MRA using Gadofosveset 3.0 T versus 1.5 T.
    Prompona M; Cyran C; Nikolaou K; Bauner K; Reiser M; Huber A
    Acad Radiol; 2010 Jul; 17(7):862-70. PubMed ID: 20399687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.